Nova Zelandija - angleščina - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - bivalirudin 250mg - powder for injection - 250 mg - active: bivalirudin 250mg excipient: mannitol sodium hydroxide - angiomax is indicated for use as an anticoagulant: · in the treatment of patients with moderate to high risk acute coronary syndromes (acs) (unstable angina/non-st segment elevation myocardial infarction (ua/nstemi) who are undergoing early invasive management, and · in patients undergoing percutaneous coronary intervention (pci). angiomax is intended for use with aspirin. a p2y12 antagonist (eg clopidogrel or ticlopidine) may be used in addition to aspirin.

Nova Zelandija - angleščina - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - pergolide mesilate 0.065mg equivalent to to 0.05 mg pergolide - tablet - 0.05 mg - active: pergolide mesilate 0.065mg equivalent to to 0.05 mg pergolide excipient: croscarmellose sodium iron oxide yellow lactose monohydrate magnesium stearate methionine povidone

Nova Zelandija - angleščina - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - pergolide mesilate 0.326mg equivalent to 0.25 mg pergolide - tablet - 0.25 mg - active: pergolide mesilate 0.326mg equivalent to 0.25 mg pergolide excipient: croscarmellose sodium indigo carmine iron oxide yellow lactose monohydrate magnesium stearate methionine povidone

Nova Zelandija - angleščina - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - pergolide mesilate 1.31mg equivalent to 1 mg pergolide - tablet - 1 mg - active: pergolide mesilate 1.31mg equivalent to 1 mg pergolide excipient: croscarmellose sodium iron oxide red lactose monohydrate magnesium stearate povidone

Združene države Amerike - angleščina - NLM (National Library of Medicine)

rebel distributors corp - azithromycin (unii: f94ow58y8v) (azithromycin - unii:f94ow58y8v) - azithromycin 2 g in 60 ml - zmax is indicated for the treatment with mild to moderate infections caused by susceptible isolates of the designated microorganisms in the specific conditions listed below. [see clinical studies (14)] acute bacterial sinusitis in adults due to haemophilus influenzae , moraxella catarrhalis or streptococcus pneumoniae . community-acquired pneumonia in adults and pediatric patients six months of age or older due to chlamydophila pneumoniae , haemophilus influenzae , mycoplasma pneumoniae or streptococcus pneumoniae, in patients appropriate for oral therapy. pediatric use in this indication is based on extrapolation of adult efficacy. [see use in specific populations (8.4)] to reduce the development of drug-resistant bacteria and maintain the effectiveness of zmax and other antibacterial drugs, zmax should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in select

Avstralija - angleščina - APVMA (Australian Pesticides and Veterinary Medicines Authority)

maxi-minerals pty ltd - glucose | potassium chloride | sodium bicarbonate | sodium chloride - nutrition & metabolism - calf - up to 4 weeks old | cattle | beef | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | cow | dairy cow - dehydration | scours | selenium responsive scours

Združene države Amerike - angleščina - NLM (National Library of Medicine)

direct rx - topiramate (unii: 0h73wjj391) (topiramate - unii:0h73wjj391) - topiramate 50 mg - 9.1 controlled substance topiramate is not a controlled substance. 9.2 abuse the abuse and dependence potential of topiramate has not been evaluated in human studies. 9.3 dependence topiramate has not been systematically studied in animals or humans for its potential for tolerance or physical dependence. 8.1 pregnancy pregnancy category d [see warnings and precautions (5.7)] topiramate can cause fetal harm when administered to a pregnant woman. data from pregnancy registries indicate that infants exposed to topiramate in utero have an increased risk for cleft lip and/or cleft palate (oral clefts). when multiple species of pregnant animals received topiramate at clinically relevant doses, structural malformations, including craniofacial defects, and reduced fetal weights occurred in offspring. topiramate should be used during pregnancy only if the potential benefit outweighs the potential risk. if this drug is used during pregnancy, or if the patient becomes pregnant while taking this drug, the patient should

Malezija - angleščina - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

sixmurs malaysia sdn. bhd. - vitex agnus-castus; glycine max -

Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

the medicines company australia pty ltd - bivalirudin -

Evropska unija - angleščina - EMA (European Medicines Agency)

teva b.v. - salmeterol xinafoate, fluticasone propionate - pulmonary disease, chronic obstructive; asthma - drugs for obstructive airway diseases, - aerivio spiromax is indicated for use in adults aged 18 years and older only.asthmaaerivio spiromax is indicated for the regular treatment of patients with severe asthma where use of a combination product (inhaled corticosteroid and long-acting β2 agonist) is appropriate:patients not adequately controlled on a lower strength corticosteroid combination product orpatients already controlled on a high dose inhaled corticosteroid and long-acting β2 agonist.chronic obstructive pulmonary disease (copd)aerivio spiromax is indicated for the symptomatic treatment of patients with copd, with a fev1